$72.210
+2.260 (+3.13%)Al cierre
Noticias de UTMD
Eventos de UTMD
Utah Medical Products Announces Quarterly Cash Dividend of $0.315
Utah Medical Products announces that its Board of Directors has approved a quarterly cash dividend of 31.5c per share of common stock payable on January 5, 2027 to stockholders of record at the close of business on December 17, 2026. This is a 1.6% increase over the prior regular quarterly cash dividend.
Utah Medical Products to Repurchase Up to 650,000 Shares at $75 Each
Utah Medical Products offered to purchase up to 650,000 shares of its common stock at $75.00 per share. The issuer Tender Offer expired Tuesday October 27. In short, 322,215 shares were purchased for $24,166,125. Remaining UTMD shares outstanding at this date are 2,854,566 including 1,775 employee option exercises in October. In addition, $107,660 administration fees will be paid to Georgeson/Computershare Inc., and $6,732 in filing fees to the SEC. The effective cost of the tender offer was 75.36/ share. Another 1% excise tax will be levied by the federal government on share repurchases.
Company Reports Revenue of $8.6M, Down from $9.8M Last Year
Reports revenue $8.6M vs. $9.8M last year.
Utah Medical Products Extends Stock Buyback to October 27
Utah Medical Products is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m. New York City time, on Wednesday October 7. In order to allow all stockholders sufficient time to make their decisions, UTMD is extending the expiration date to 5:00 p.m. New York City time, on Tuesday October 27. The time extension provides the added benefit of allowing stockholders to consider UTMD's latest financial results for calendar 3Q 2026 which are scheduled to be announced on Thursday October 22.
Utah Medical Products to Buy Back 650,000 Shares at $75 Each
Utah Medical Products is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The $75.00 per share price represents a 17% premium over the average daily closing price of the stock during the last twelve months, and a 21% premium over the average daily closing price of the stock during the last twenty-four months.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.